Anadys, Structural GenomiX Form Antibacterials Alliance

Feb. 21, 2002

By Aaron Lorenzo

Cytyc Acquiring Digene In Stock, Cash Deal Worth $554M

Feb. 20, 2002

By Aaron Lorenzo

Cytyc Acquiring Digene In Stock, Cash Deal Worth $554M

Feb. 20, 2002

By Aaron Lorenzo

Norak Closes Series B, Raises $13M For Screening Platform

Feb. 7, 2002

By Aaron Lorenzo

Chiron Licenses TB Product To Public-Private Partnership

Feb. 4, 2002

By Aaron Lorenzo

Biogen, Genaissance Align In Pharmacogenomics Area

Feb. 4, 2002

By Aaron Lorenzo

Biogen, Genaissance Align In Pharmacogenomics Area

Feb. 4, 2002

By Aaron Lorenzo

Chiron Licenses TB Product To Public-Private Partnership

Feb. 4, 2002

By Aaron Lorenzo

Intradigm, DirectGene Team Up To Develop Cancer Therapeutics

Jan. 28, 2002

By Aaron Lorenzo

Intradigm, DirectGene Team Up To Develop Cancer Therapeutics

Jan. 28, 2002

By Aaron Lorenzo